Clinical Trials Browser

Completed × Hematologic Diseases × Cytarabine × Clear all

NCT01191801 2018-08-22

VALOR

Phase 3 Completed

711 enrolled 15 charts

Other hematologic neoplasm

Hematologic Diseases, Leukemia, Neoplasms, Leukemia, Myeloid, Acute

NCT00528333 2015-01-07

A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML

Phase 2 Completed

Other hematologic neoplasm

Hematologic Diseases, Leukemia, Leukemia, Myeloid, Acute